Lincoln Pharmaceuticals Share Price
Start SIP in Lincoln Pharmaceuticals
Start SIPLincoln Pharmaceuticals Performance
Day Range
- Low 763
- High 781
52 Week Range
- Low 472
- High 812
- Open Price775
- Previous Close772
- Volume52409
Lincoln Pharmaceuticals Investment Rating
-
Master Rating:
-
Lincoln Pharmaceuticals has an operating revenue of Rs. 592.21 Cr. on a trailing 12-month basis. An annual revenue growth of 15% is outstanding, Pre-tax margin of 21% is great, ROE of 15% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 13% and 20% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 12% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 85 which is a GOOD score indicating consistency in earnings, a RS Rating of 60 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 56 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 147 | 142 | 146 | 156 | 136 | 112 |
| Operating Expenses Qtr Cr | 125 | 124 | 117 | 125 | 115 | 96 |
| Operating Profit Qtr Cr | 23 | 18 | 30 | 31 | 21 | 17 |
| Depreciation Qtr Cr | 3 | 3 | 3 | 3 | 3 | 2 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 1 |
| Tax Qtr Cr | 6 | 4 | 10 | 9 | 6 | 4 |
| Net Profit Qtr Cr | 24 | 19 | 28 | 28 | 19 | 13 |
Lincoln Pharmaceuticals Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 14
- Bearish Moving Average
- ___
- 2
- 20 Day
- ₹734.88
- 50 Day
- ₹693.00
- 100 Day
- ₹661.12
- 200 Day
- ₹622.07
- 20 Day
- ₹730.97
- 50 Day
- ₹683.30
- 100 Day
- ₹638.25
- 200 Day
- ₹639.41
Lincoln Pharmaceuticals Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 777.53 |
| Second Resistance | 788.57 |
| Third Resistance | 796.03 |
| RSI | 65.73 |
| MFI | 71.47 |
| MACD Single Line | 25.82 |
| MACD | 29.52 |
| Support | |
|---|---|
| First Support | 759.03 |
| Second Support | 751.57 |
| Third Supoort | 740.53 |
Lincoln Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 62,103 | 3,618,121 | 58.26 |
| Week | 150,001 | 6,774,045 | 45.16 |
| 1 Month | 160,935 | 6,474,413 | 40.23 |
| 6 Month | 86,029 | 3,999,500 | 46.49 |
Lincoln Pharmaceuticals Result Highlights
Lincoln Pharmaceuticals Synopsis
NSE-Medical-Diversified
Lincoln Pharmace is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 510.31 Cr. and Equity Capital is Rs. 20.03 Cr. for the Year ended 31/03/2023. Lincoln Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 20/01/1995 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1995PLC024288 and registration number is 024288.| Market Cap | 1,535 |
| Sales | 592 |
| Shares in Float | 1.00 |
| No of funds | 39 |
| Yield | 0.23 |
| Book Value | 2.59 |
| U/D Vol ratio | 1.4 |
| LTDebt / Equity | |
| Alpha | 0.07 |
| Beta | 1 |
Lincoln Pharmaceuticals Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 49.78% | 49.53% | 49.8% | 50.53% |
| Mutual Funds | ||||
| Foreign Portfolio Investors | 3.95% | 3.93% | 3.22% | 2.59% |
| Individual Investors | 37.1% | 37.36% | 37.78% | 37.47% |
| Others | 9.17% | 9.18% | 9.2% | 9.41% |
Lincoln Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Kishor M Shah | Chairman |
| Mr. Mahendra G Patel | Managing Director |
| Mr. Hashmukh I Patel | Whole Time Director |
| Mr. Munjal M Patel | Whole Time Director |
| Mr. Ashish R Patel | Whole Time Director |
| Mr. Rajnikant G Patel | Non Executive Director |
| Mr. Meha M Patel | Independent Director |
| Mr. Saurin J Parikh | Independent Director |
| Mr. Pirabhai R Suthar | Independent Director |
Lincoln Pharmaceuticals Forecast
Price Estimates
Lincoln Pharmaceuticals Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-08 | Quarterly Results | |
| 2024-05-16 | Audited Results & Final Dividend | |
| 2024-02-08 | Quarterly Results | |
| 2023-11-02 | Quarterly Results | |
| 2023-08-10 | Quarterly Results |
Lincoln Pharmaceuticals FAQs
What is Share Price of Lincoln Pharmaceuticals ?
Lincoln Pharmaceuticals share price is ₹766 As on 16 September, 2024 | 05:22
What is the Market Cap of Lincoln Pharmaceuticals ?
The Market Cap of Lincoln Pharmaceuticals is ₹1535.3 Cr As on 16 September, 2024 | 05:22
What is the P/E ratio of Lincoln Pharmaceuticals ?
The P/E ratio of Lincoln Pharmaceuticals is 15.7 As on 16 September, 2024 | 05:22
What is the PB ratio of Lincoln Pharmaceuticals ?
The PB ratio of Lincoln Pharmaceuticals is 2.6 As on 16 September, 2024 | 05:22